...
首页> 外文期刊>Journal of Clinical Research Best Practices >On Site: Pandemic Prompts Trials to Reinvent Themselves, Woodcock Says
【24h】

On Site: Pandemic Prompts Trials to Reinvent Themselves, Woodcock Says

机译:现场:Woodcock说,大流行提示试验重塑自己

获取原文
           

摘要

“COVID-19 should come as a prompt to the clinical research sector to rapidly reinvent itself as it works to design and launch clinical trials for vaccine and therapeutic candidates ‘in the teeth of the epidemic,’ says Janet Woodcock, director of FDA’s Center for Drug Evaluation and Research.
机译:“Covid-19应该是临床研究领域的促销,以便迅速重新发明,因为它适用于设计和发射疫苗和治疗性候选人的临床试验,”FDA中心主任Janet Woodcock说,药物评估与研究。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号